24 results
424B3
PTPI
Petros Pharmaceuticals Inc
23 Nov 21
Prospectus supplement
4:11pm
to distribute the securities.
We are required to pay certain fees and expenses incurred by us incident to the registration of the securities. We have
424B3
PTPI
Petros Pharmaceuticals Inc
20 Dec 21
Prospectus supplement
7:24am
and expenses incurred by us incident to the registration of the securities. We have agreed to indemnify the selling stockholders against certain losses
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
price of any Warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and expenses incident to our
S-1
PTPI
Petros Pharmaceuticals Inc
12 Nov 21
IPO registration
5:03pm
incurred by us incident to the registration of the securities. We have agreed to indemnify the selling stockholders against certain losses, claims, damages
8-K
EX-3.2
PTPI
Petros Pharmaceuticals Inc
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
president, is authorized to vote, represent, and exercise on behalf of this corporation all rights incident to any and all shares of any other corporation
8-K
EX-10.2
059kv q260ojpzw8f
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
POS AM
v2qika
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
8-K
EX-10.1
96x7pjm089uiumdzp
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
8-K
EX-10.1
2vy6mxcl
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
mwuook
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
8-K
EX-10.1
39kl2vq48k1toi8m5cmx
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm